Seattle | June 21, 2016
FOR IMMEDIATE RELEASE: SEATTLE, June 21, 2016 : IDRI (Infectious Disease Research Institute) is expanding its Board of Directors with the recent addition of Steve Cordial, a multi-disciplined financial executive with expertise in both nonprofit and corporate arenas, and Kari Stoever, a global development expert with experience in public health start-ups and advocacy movements.
“IDRI is fortunate to have a board that includes scientific leaders from around the world; now we are expanding the board to add expertise in strategic areas, including finance and global development/advocacy, that support our continued growth,” said Steven G. Reed, Ph.D., IDRI Founder, President and Chief Scientific Officer. “Steve and Kari are proven leaders in their respective fields, and IDRI will benefit from their extensive knowledge in the nonprofit field.”
Stoever currently serves as Chief External Relations Officer at the Lieber Institute for Brain Development in Baltimore, MD. Prior to that, she was the Director of Co-Investments at the Nike Foundation’s Girl Effect, where she led a $210 million partnership between the President’s Emergency Plan for AIDS Relief (PEPFAR) and the Bill & Melinda Gates Foundation to reduce new HIV infections in adolescent girls and young women.
Stoever previously served as Vice President of External Affairs at Aeras, a nonprofit focused on developing next generation tuberculosis vaccines; as President and Founder of Meliora Global LLC, a firm focused on growth strategies for nonprofits and social ventures; and as Managing Director of the Global Network for Neglected Tropical Diseases for the Sabin Institute. Prior to her work at Sabin, Stoever spent several years managing clinical research studies in cancer and infectious diseases.
She served as part of the U.S. Presidential task force that promoted entrepreneurship around the world and has been active in the Clinton Global Initiative since its inception. She holds a B.Sc. from George Washington University, a degree in nursing and an Executive Masters in Leadership from the McDonough School of Business, Georgetown University.
“It is an honor to be a part of the IDRI team,” said Stoever. “IDRI is on the front lines of the global battle to fight deadly infectious diseases and the crisis of antimicrobial resistance. Support for IDRI’s mission, and highly collaborative partnership model, is critical to bridging the gap between wealthy and poor nations when it comes to access for healthcare innovations.”
For the past 11 years, Cordial has served as president of Steve Cordial Consulting, where he has provided interim financial leadership support for a variety of companies, ranging from a private-equity owned personal care company with more than $400 million in revenues to a $29 million per year venture-backed telecom equipment manufacturer.
Prior to starting his own firm, Cordial served as CFO and CEO at Somera Communications, CFO at Nexsi Systems, CFO at Xylan Corp. and CFO at Sierra Semiconductor. He started his career as a Division Controller at Texas Instruments.
Cordial holds a BA in economics from Stanford University and an MBA from Santa Clara University. Working as a community volunteer, he has developed experience in nonprofit accounting. He serves as a partner at Social Venture Partners Seattle and hold board positions at TeamChild and at the Kindering Center, where he serves as treasurer and as a member of the advocacy and governance committees. In addition to serving as the chair of IDRI’s finance committee, Cordial is also serving as interim CFO for IDRI.
“Through my work with nonprofits, I’ve been able to help improve internal processes and keep organizations focused on their mission while increasing capacity,” said Cordial. “IDRI has grown tremendously during the past few years and I look forward to helping the organization realize the full potential of this growth by having the most effective systems in place to support the great science being done here.”
As a non-profit global health organization, IDRI (Infectious Disease Research Institute) takes a comprehensive approach to combat infectious diseases, combining the high-quality science of a research organization with the product development capabilities of a biotech company to create new diagnostics, drugs and vaccines. IDRI combines passion for improving human health with the understanding that it is not just what our scientists know about disease, but what we do to change its course that will have the greatest impact. Founded in 1993, IDRI has 125 employees headquartered in Seattle with nearly 100 partners/collaborators around the world. For more information, visit www.idri.org.
IDRI: Lee Schoentrup | 206.858.6064 | email@example.com